Optical Kerr nonlinearity and ultrafast photo-excited carrier dynamics in CePO 4 /g-C 3 N 4 heterojunctions: mechanistic insight into a 3D/2D interface for optical limiting
Journal of Materials Chemistry C · 2025 · 13 (31) · 16210-16231
DOI: 10.1039/d5tc01767j ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry C, 2025. Verfasst von Vijayakumar Balakrishnan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Defence Research and Development Organisation.
Abstract (Originalsprache)
Femtosecond and nanosecond pulsed laser Z-scan technique reveals two-photon absorption behaviour ( β ∼ 10 −8 m W −1 ) and a self-focusing effect in CePO 4 /g-C 3 N 4 ( n 2 ∼ 10 −15 cm 2 W −1 ) manifesting it as a potential candidate for optical limiting.
Förderung
- Defence Research and Development Organisation
Zitieren
APA
Balakrishnan, V., Soma, V. R., Chidambaram, S. G., & Flower, N. A. L. (2025). Optical Kerr nonlinearity and ultrafast photo-excited carrier dynamics in CePO 4 /g-C 3 N 4 heterojunctions: mechanistic insight into a 3D/2D interface for optical limiting. Journal of Materials Chemistry C, 13(31), 16210-16231. https://doi.org/10.1039/d5tc01767j
Vancouver
Balakrishnan V, Soma VR, Chidambaram SG, Flower NAL. Optical Kerr nonlinearity and ultrafast photo-excited carrier dynamics in CePO 4 /g-C 3 N 4 heterojunctions: mechanistic insight into a 3D/2D interface for optical limiting. Journal of Materials Chemistry C. 2025;13(31):16210-16231. doi:10.1039/d5tc01767j
BibTeX
@article{Balakrishnan2025,
author = {Balakrishnan, Vijayakumar and Soma, Venugopal Rao and Chidambaram, Sabari Girisun and Flower, N Angeline Little},
title = {Optical Kerr nonlinearity and ultrafast photo-excited carrier dynamics in CePO 4 /g-C 3 N 4 heterojunctions: mechanistic insight into a 3D/2D interface for optical limiting},
journal = {Journal of Materials Chemistry C},
year = {2025},
volume = {13},
number = {31},
pages = {16210--16231},
doi = {10.1039/d5tc01767j}
}
EUVIMED